North America Low Molecular Weight Heparin Market by Manufacturers, Countries, Type and Application, Forecast to 2022
'Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da. '
Scope of the Report:
This report focuses on the Low Molecular Weight Heparin in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Low Molecular Weight Heparin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Low Molecular Weight Heparin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Low Molecular Weight Heparin, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Low Molecular Weight Heparin market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Low Molecular Weight Heparin Research Findings and Conclusion, Appendix, methodology and data source
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da. '
Scope of the Report:
This report focuses on the Low Molecular Weight Heparin in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
- Aspen
- Sanofi-aventis
- Pfizer
- Opocrin
- CSBIO
- Dongying Tiandong Pharmaceutical
- Changzhou Qianhong Bio-pharma
- Techdow
- Yantai Dongcheng Pharmaceutical Group
- United States
- Canada
- Mexico
- Enoxaparin
- Dalteparin
- Tinzaparin
- Fraxiparine
- Treatment of Venous Thromboembolism
- Complications of Pregnancy
- Cardioversion of Atrial Fibrillation/Flutter
- Others
Chapter 1, to describe Low Molecular Weight Heparin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Low Molecular Weight Heparin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Low Molecular Weight Heparin, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Low Molecular Weight Heparin market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Low Molecular Weight Heparin Research Findings and Conclusion, Appendix, methodology and data source
1 MARKET OVERVIEW
1.1 Low Molecular Weight Heparin Introduction
1.2 Market Analysis by Type
1.2.1 Enoxaparin
1.2.2 Dalteparin
1.2.3 Tinzaparin
1.2.4 Fraxiparine
1.3 Market Analysis by Applications
1.3.1 Treatment of Venous Thromboembolism
1.3.2 Complications of Pregnancy
1.3.3 Cardioversion of Atrial Fibrillation/Flutter
1.3.4 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Aspen
2.1.1 Profile
2.1.2 Low Molecular Weight Heparin Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 Aspen Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Aspen News
2.2 Sanofi-aventis
2.2.1 Profile
2.2.2 Low Molecular Weight Heparin Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Sanofi-aventis News
2.3 Pfizer
2.3.1 Profile
2.3.2 Low Molecular Weight Heparin Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Pfizer News
2.4 Opocrin
2.4.1 Profile
2.4.2 Low Molecular Weight Heparin Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Opocrin News
2.5 CSBIO
2.5.1 Profile
2.5.2 Low Molecular Weight Heparin Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 CSBIO News
2.6 Dongying Tiandong Pharmaceutical
2.6.1 Profile
2.6.2 Low Molecular Weight Heparin Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Dongying Tiandong Pharmaceutical News
2.7 Changzhou Qianhong Bio-pharma
2.7.1 Profile
2.7.2 Low Molecular Weight Heparin Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Changzhou Qianhong Bio-pharma News
2.8 Techdow
2.8.1 Profile
2.8.2 Low Molecular Weight Heparin Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 Techdow Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Techdow News
2.9 Yantai Dongcheng Pharmaceutical Group
2.9.1 Profile
2.9.2 Low Molecular Weight Heparin Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Yantai Dongcheng Pharmaceutical Group News
3 NORTH AMERICA LOW MOLECULAR WEIGHT HEPARIN MARKET COMPETITION, BY MANUFACTURER
3.1 North America Low Molecular Weight Heparin Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Low Molecular Weight Heparin Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Low Molecular Weight Heparin Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Low Molecular Weight Heparin Manufacturer Market Share
3.4.2 Top 5 Low Molecular Weight Heparin Manufacturer Market Share
3.5 Market Competition Trend
4 NORTH AMERICA LOW MOLECULAR WEIGHT HEPARIN MARKET ANALYSIS BY COUNTRIES
4.1 North America Low Molecular Weight Heparin Sales Market Share by Countries
4.2 North America Low Molecular Weight Heparin Sales by Countries (2012-2017)
4.3 North America Low Molecular Weight Heparin Revenue (Value) by Countries (2012-2017)
5 NORTH AMERICA MARKET SEGMENTATION LOW MOLECULAR WEIGHT HEPARIN BY TYPE
5.1 North America Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Low Molecular Weight Heparin Sales and Market Share by Type (2012-2017)
5.1.2 North America Low Molecular Weight Heparin Revenue and Market Share by Type (2012-2017)
5.2 Enoxaparin Sales Growth and Price
5.2.1 North America Enoxaparin Sales Growth (2012-2017)
5.2.2 North America Enoxaparin Price (2012-2017)
5.3 Dalteparin Sales Growth and Price
5.3.1 North America Dalteparin Sales Growth (2012-2017)
5.3.2 North America Dalteparin Price (2012-2017)
5.4 Tinzaparin Sales Growth and Price
5.4.1 North America Tinzaparin Sales Growth (2012-2017)
5.4.2 North America Tinzaparin Price (2012-2017)
5.5 Fraxiparine Sales Growth and Price
5.5.1 North America Fraxiparine Sales Growth (2012-2017)
5.5.2 North America Fraxiparine Price (2012-2017)
6 NORTH AMERICA MARKET SEGMENTATION LOW MOLECULAR WEIGHT HEPARIN BY APPLICATION
6.1 North America Low Molecular Weight Heparin Sales Market Share by Application (2012-2017)
6.2 Treatment of Venous Thromboembolism Sales Growth (2012-2017)
6.3 Complications of Pregnancy Sales Growth (2012-2017)
6.4 Cardioversion of Atrial Fibrillation/Flutter Sales Growth (2012-2017)
6.5 Others Sales Growth (2012-2017)
7 UNITED STATES LOW MOLECULAR WEIGHT HEPARIN SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 United States Low Molecular Weight Heparin Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Low Molecular Weight Heparin Sales and Market Share by Type
7.3 United States Low Molecular Weight Heparin Sales by Application (2012-2017)
7.4 United States Low Molecular Weight Heparin Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Low Molecular Weight Heparin Sales and Market Share by Manufacturer
7.4.2 United States Low Molecular Weight Heparin Revenue and Market Share by Manufacturer
7.5 United States Low Molecular Weight Heparin Export and Import (2012-2017)
8 CANADA LOW MOLECULAR WEIGHT HEPARIN SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 Canada Low Molecular Weight Heparin Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Low Molecular Weight Heparin Sales and Market Share by Type
8.3 Canada Low Molecular Weight Heparin Sales by Application (2012-2017)
8.4 Canada Low Molecular Weight Heparin Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Low Molecular Weight Heparin Sales and Market Share by Manufacturer
8.4.2 Canada Low Molecular Weight Heparin Revenue and Market Share by Manufacturer
8.5 Canada Low Molecular Weight Heparin Export and Import (2012-2017)
9 MEXICO LOW MOLECULAR WEIGHT HEPARIN SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 Mexico Low Molecular Weight Heparin Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Low Molecular Weight Heparin Sales and Market Share by Type
9.3 Mexico Low Molecular Weight Heparin Sales by Application (2012-2017)
9.4 Mexico Low Molecular Weight Heparin Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Low Molecular Weight Heparin Sales and Market Share by Manufacturer
9.4.2 Mexico Low Molecular Weight Heparin Revenue and Market Share by Manufacturer
9.5 Mexico Low Molecular Weight Heparin Export and Import (2012-2017)
10 LOW MOLECULAR WEIGHT HEPARIN MARKET FORECAST (2017-2022)
10.1 North America Low Molecular Weight Heparin Sales, Revenue and Growth Rate (2017-2022)
10.2 Low Molecular Weight Heparin Market Forecast by Countries (2017-2022)
10.2.1 United States Low Molecular Weight Heparin Forecast (2017-2022)
10.2.2 Canada Low Molecular Weight Heparin Forecast (2017-2022)
10.2.3 Mexico Low Molecular Weight Heparin Forecast (2017-2022)
10.3 Low Molecular Weight Heparin Market Forecast by Type (2017-2022)
10.4 Low Molecular Weight Heparin Market Forecast by Application (2017-2022)
11 LOW MOLECULAR WEIGHT HEPARIN MANUFACTURING COST ANALYSIS
11.1 Low Molecular Weight Heparin Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Low Molecular Weight Heparin
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 Low Molecular Weight Heparin Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Low Molecular Weight Heparin Major Manufacturers in 2016
12.4 Downstream Buyers
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
1.1 Low Molecular Weight Heparin Introduction
1.2 Market Analysis by Type
1.2.1 Enoxaparin
1.2.2 Dalteparin
1.2.3 Tinzaparin
1.2.4 Fraxiparine
1.3 Market Analysis by Applications
1.3.1 Treatment of Venous Thromboembolism
1.3.2 Complications of Pregnancy
1.3.3 Cardioversion of Atrial Fibrillation/Flutter
1.3.4 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Aspen
2.1.1 Profile
2.1.2 Low Molecular Weight Heparin Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 Aspen Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Aspen News
2.2 Sanofi-aventis
2.2.1 Profile
2.2.2 Low Molecular Weight Heparin Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Sanofi-aventis News
2.3 Pfizer
2.3.1 Profile
2.3.2 Low Molecular Weight Heparin Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Pfizer News
2.4 Opocrin
2.4.1 Profile
2.4.2 Low Molecular Weight Heparin Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Opocrin News
2.5 CSBIO
2.5.1 Profile
2.5.2 Low Molecular Weight Heparin Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 CSBIO News
2.6 Dongying Tiandong Pharmaceutical
2.6.1 Profile
2.6.2 Low Molecular Weight Heparin Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Dongying Tiandong Pharmaceutical News
2.7 Changzhou Qianhong Bio-pharma
2.7.1 Profile
2.7.2 Low Molecular Weight Heparin Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Changzhou Qianhong Bio-pharma News
2.8 Techdow
2.8.1 Profile
2.8.2 Low Molecular Weight Heparin Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 Techdow Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Techdow News
2.9 Yantai Dongcheng Pharmaceutical Group
2.9.1 Profile
2.9.2 Low Molecular Weight Heparin Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Yantai Dongcheng Pharmaceutical Group News
3 NORTH AMERICA LOW MOLECULAR WEIGHT HEPARIN MARKET COMPETITION, BY MANUFACTURER
3.1 North America Low Molecular Weight Heparin Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Low Molecular Weight Heparin Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Low Molecular Weight Heparin Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Low Molecular Weight Heparin Manufacturer Market Share
3.4.2 Top 5 Low Molecular Weight Heparin Manufacturer Market Share
3.5 Market Competition Trend
4 NORTH AMERICA LOW MOLECULAR WEIGHT HEPARIN MARKET ANALYSIS BY COUNTRIES
4.1 North America Low Molecular Weight Heparin Sales Market Share by Countries
4.2 North America Low Molecular Weight Heparin Sales by Countries (2012-2017)
4.3 North America Low Molecular Weight Heparin Revenue (Value) by Countries (2012-2017)
5 NORTH AMERICA MARKET SEGMENTATION LOW MOLECULAR WEIGHT HEPARIN BY TYPE
5.1 North America Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Low Molecular Weight Heparin Sales and Market Share by Type (2012-2017)
5.1.2 North America Low Molecular Weight Heparin Revenue and Market Share by Type (2012-2017)
5.2 Enoxaparin Sales Growth and Price
5.2.1 North America Enoxaparin Sales Growth (2012-2017)
5.2.2 North America Enoxaparin Price (2012-2017)
5.3 Dalteparin Sales Growth and Price
5.3.1 North America Dalteparin Sales Growth (2012-2017)
5.3.2 North America Dalteparin Price (2012-2017)
5.4 Tinzaparin Sales Growth and Price
5.4.1 North America Tinzaparin Sales Growth (2012-2017)
5.4.2 North America Tinzaparin Price (2012-2017)
5.5 Fraxiparine Sales Growth and Price
5.5.1 North America Fraxiparine Sales Growth (2012-2017)
5.5.2 North America Fraxiparine Price (2012-2017)
6 NORTH AMERICA MARKET SEGMENTATION LOW MOLECULAR WEIGHT HEPARIN BY APPLICATION
6.1 North America Low Molecular Weight Heparin Sales Market Share by Application (2012-2017)
6.2 Treatment of Venous Thromboembolism Sales Growth (2012-2017)
6.3 Complications of Pregnancy Sales Growth (2012-2017)
6.4 Cardioversion of Atrial Fibrillation/Flutter Sales Growth (2012-2017)
6.5 Others Sales Growth (2012-2017)
7 UNITED STATES LOW MOLECULAR WEIGHT HEPARIN SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 United States Low Molecular Weight Heparin Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Low Molecular Weight Heparin Sales and Market Share by Type
7.3 United States Low Molecular Weight Heparin Sales by Application (2012-2017)
7.4 United States Low Molecular Weight Heparin Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Low Molecular Weight Heparin Sales and Market Share by Manufacturer
7.4.2 United States Low Molecular Weight Heparin Revenue and Market Share by Manufacturer
7.5 United States Low Molecular Weight Heparin Export and Import (2012-2017)
8 CANADA LOW MOLECULAR WEIGHT HEPARIN SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 Canada Low Molecular Weight Heparin Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Low Molecular Weight Heparin Sales and Market Share by Type
8.3 Canada Low Molecular Weight Heparin Sales by Application (2012-2017)
8.4 Canada Low Molecular Weight Heparin Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Low Molecular Weight Heparin Sales and Market Share by Manufacturer
8.4.2 Canada Low Molecular Weight Heparin Revenue and Market Share by Manufacturer
8.5 Canada Low Molecular Weight Heparin Export and Import (2012-2017)
9 MEXICO LOW MOLECULAR WEIGHT HEPARIN SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 Mexico Low Molecular Weight Heparin Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Low Molecular Weight Heparin Sales and Market Share by Type
9.3 Mexico Low Molecular Weight Heparin Sales by Application (2012-2017)
9.4 Mexico Low Molecular Weight Heparin Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Low Molecular Weight Heparin Sales and Market Share by Manufacturer
9.4.2 Mexico Low Molecular Weight Heparin Revenue and Market Share by Manufacturer
9.5 Mexico Low Molecular Weight Heparin Export and Import (2012-2017)
10 LOW MOLECULAR WEIGHT HEPARIN MARKET FORECAST (2017-2022)
10.1 North America Low Molecular Weight Heparin Sales, Revenue and Growth Rate (2017-2022)
10.2 Low Molecular Weight Heparin Market Forecast by Countries (2017-2022)
10.2.1 United States Low Molecular Weight Heparin Forecast (2017-2022)
10.2.2 Canada Low Molecular Weight Heparin Forecast (2017-2022)
10.2.3 Mexico Low Molecular Weight Heparin Forecast (2017-2022)
10.3 Low Molecular Weight Heparin Market Forecast by Type (2017-2022)
10.4 Low Molecular Weight Heparin Market Forecast by Application (2017-2022)
11 LOW MOLECULAR WEIGHT HEPARIN MANUFACTURING COST ANALYSIS
11.1 Low Molecular Weight Heparin Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Low Molecular Weight Heparin
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 Low Molecular Weight Heparin Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Low Molecular Weight Heparin Major Manufacturers in 2016
12.4 Downstream Buyers
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
LIST OF TABLES AND FIGURES
Figure Low Molecular Weight Heparin Picture
Table Product Specifications of Low Molecular Weight Heparin
Figure North America Sales Market Share of Low Molecular Weight Heparin by Types in 2016
T
Figure Low Molecular Weight Heparin Picture
Table Product Specifications of Low Molecular Weight Heparin
Figure North America Sales Market Share of Low Molecular Weight Heparin by Types in 2016
T
